Penn study finds GLP-1 use associated with lower breast cancer risk
Transl Psychiatry 10:238 van der Valk ME, Mangen MJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk C, Vermeijden JR, Siersema PD, Leenders M, Oldenburg B (2016) Evolution of costs of inflammatory bowel disease over two years of follow-up
Step-by-step protocol for drawing a 1.25 mg dose This protocol assumes a 10 mg/mL pre-mixed compounded tirzepatide vial and a 0.3 mL U-100 insulin syringe with half-unit markings
Eat small amounts
Restrictions may apply to route or other details, as demonstrated by entries in the current regulation that are limited to topical use